Clinical Trial Update: Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating dasatinib in combination with chemotherapy for newly diagnosed acute lymphoblastic leukemia, including BCR-ABL1-positive sub…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-10-07